WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Introducing ALZET?ew Model 2006 Pump
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (127)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vicini, S.
Right arrow Articles by Homanics, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vicini, S.
Right arrow Articles by Homanics, G. E.

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 1, 2001, 21(9):3009-3016

GABAA Receptor alpha 1 Subunit Deletion Prevents Developmental Changes of Inhibitory Synaptic Currents in Cerebellar Neurons

Stefano Vicini1, Carolyn Ferguson2, Kate Prybylowski1, Jason Kralic3, A. Leslie Morrow3, and Gregg E. Homanics2

1 Department of Physiology and Biophysics, Georgetown University Medical School, Washington, DC 20007, 2 Departments of Anesthesiology/Critical Care Medicine and Pharmacology, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, and 3 Department of Psychiatry and Pharmacology, University of North Carolina Medical School, Chapel Hill, North Carolina 27599-7178


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Developmental changes in miniature IPSC (mIPSC) kinetics have been demonstrated previously in cerebellar neurons in rodents. We report that these kinetic changes in mice are determined primarily by developmental changes in GABAA receptor subunit expression. mIPSCs were studied by whole-cell recordings in cerebellar slices, prepared from postnatal day 11 (P11) and P35 mice. Similar to reports in granule neurons, wild-type cerebellar stellate neuron mIPSCs at P11 had slow decay kinetics, whereas P35 mIPSCs decayed five times faster. When mIPSCs in cerebellar stellate neurons were compared between wild-type (+/+) and GABAA receptor alpha 1 subunit-deficient (-/-) littermates at P35, we observed dramatically slower mIPSC decay rates in -/- animals. We took advantage of the greater potency of imidazopyridines for GABA current potentiation with alpha 1 subunit-containing receptors to characterize the relative contribution of alpha 1 subunits in native receptors on inhibitory synapses of cerebellar granule neurons. Zolpidem-induced prolongation of mIPSC decay was variable among distinct cells, but it increased during development in wild-type mice. Similarly, Zolpidem prolongation of mIPSC decay rate was significantly greater in adult +/+ mice than in knock-outs. We propose that an increased alpha 1 subunit assembly in postsynaptic receptors of cerebellar inhibitory synapses is responsible for the fast inhibitory synaptic currents that are normally observed during postnatal development.

Key words: GABA receptor; gene knock-out; patch-clamp; inhibitory synapses; development; GABA


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Spontaneous IPSCs (sIPSCs) and miniature IPSCs (mIPSCs) [recorded in the presence of tetrodotoxin (TTX)] in mammalian neurons have been shown to become faster with development (Brickley et al., 1996; Draguhn and Heinemann, 1996; Tia et al., 1996; Brussard et al., 1997; Hollrigel and Soltesz, 1997; Pouzat and Hestrin, 1997; Dunning et al., 1999; Okada et al., 2000). Several mechanisms have been proposed to explain these changes, including changes in expression of specific GABAA receptor (GABAA-R) subunits (Tia et al., 1996; Dunning et al., 2000; Okada et al., 2000) and changes in reuptake mechanisms (Draguhn and Heinemann, 1996). Recent studies with overexpression of the alpha 1 subunit of the GABAA receptor in thalamic neurons have indicated that the enhanced expression of the alpha 1 subunit could be responsible for faster mIPSCs (Okada et al., 2000). This hypothesis is supported by work in recombinant systems that demonstrate that rapid application of brief pulses of GABA to outside-out excised patches generates faster currents with alpha 1beta 2gamma 2 than with other subunit combinations (Verdoorn, 1994; Gingrich et al., 1995; Lavoie et al., 1997; McClellan and Twyman, 1999).

sIPSCs have been characterized extensively in granule and stellate neurons in rat cerebellar slices (Llano and Gerschenfeld, 1993; Brickley et al., 1996, 1999; Tia et al., 1996; Nusser et al., 1997; Kondo and Marty, 1998). The decay time of sIPSCs in granule neurons has been shown to undergo a developmental decrease (Brickley et al., 1996; Tia et al., 1996). Whereas in granule neurons many distinct subunits are expressed, in stellate neurons, mRNAs have been found only for the alpha 1, beta 2, and gamma 2 subunits of the GABAA receptor, although low levels of mRNA for alpha 2 and alpha 3 subunits were seen early in development (Laurie et al., 1992a,b). It is therefore of interest to assess whether developmental changes of mIPSC kinetics can be observed in stellate neurons that should therefore express a more restricted number of receptor subtypes.

In situ hybridization studies have shown a selective increase with development of alpha 1 and the alpha 6 subunits in the total cerebellum (Bovolin et al., 1992; Laurie et al., 1992b). However, the developmental changes of sIPSCs kinetics also occurred in granule cells in mutant mice lacking alpha 6 (Farrant et al., 1999). Our aim was to investigate the role of the alpha 1 subunit in kinetic changes of mIPSCs in developing cerebellar stellate and granule neurons using mutant mice lacking this subunit. To further support that these changes are related to the relative contributions of the alpha 1 subunit, we studied the sensitivity of mIPSCs to the imidazopyridine Zolpidem, which has been shown to have selectivity for the benzodiazepine type 1 receptor that contains alpha 1 subunits (Pritchett et al., 1989; MacDonald and Olsen, 1994).


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Mutant mouse production. A 775bp BstEII-BspEI fragment of the bovine GABAA receptor alpha 1 subunit cDNA (Schofield et al., 1987) was used to screen a strain 129/SvJ mouse genomic DNA BAC library (Genome Systems, St. Louis, MO) for the murine alpha 1 subunit. From one of these BAC clones, a ~13 kb BamHI fragment was subcloned and characterized. This clone contained an exon that corresponded to nucleotides 1307-1509 of the mouse cDNA (Keir et al., 1991). This genomic clone was used to create the targeting construct illustrated in Figure 1A. The selectable marker gene PGKneoNTRtkpA (Wu et al., 1994) was flanked by loxP sites (Sternberg and Hamilton, 1981) and inserted into an EcoRV site ~0.6 kb upstream of the exon. An oligonucleotide that harbored an EcoRI site and an additional loxP site was inserted into a BglII site ~0.8 kb downstream of the exon. This construct was linearized in the vector backbone with PvuI and electroporated into R1 mouse embryonic stem (ES) cells (Nagy et al., 1990) as described previously (Homanics et al., 1997). ES cell clones surviving G418 selection (270 µg/ml; Life Technologies, Gaithersburg, MD) were screened for gene targeting by Southern blot analysis of genomic DNA after digestion with EcoRI. Blots were hybridized with probe C (see Fig. 1A, C), which is external to the targeting construct.

The selectable marker cassette was removed in vitro from two ES cell clones that were correctly targeted. To accomplish this, these clones were transiently transfected by electroporation with 20 µg of supercoiled CRE expression plasmid pBS185 (Life Technologies). Immediately after transfection, ES cells were plated at various dilutions. From 2 to 12 d after transfection, cells were subjected to gancyclovir selection (2 µM; Syntex, Palo Alto, CA) to enrich for cells that had deleted the marker gene. Surviving clones were picked and analyzed for CRE-mediated recombination by Southern blot analysis of BamHI-digested DNA. Blots were hybridized with probe A (see Fig. 1A, A).

Four ES cell clones that harbored the targeted locus but lacked the marker gene (F) (see Fig. 1A) were injected into C57BL/6J blastocysts to produce chimeric mice. Highly chimeric animals were mated to C57BL/6J females to establish germ line transmission. Heterozygous (F/+) mice of the F1 generation were interbred. Homozygous (F/F) mice were subsequently mated to an actin-CRE general deleter transgenic mouse line on an FVB/N genetic background (Lewandoski et al., 1997) to create the GABAA receptor alpha 1 null allele (-). Mice that were heterozygous for the alpha 1 null allele (+/-) and positive for the cre transgene were mated to mice that were heterozygous for the targeted alpha 1 locus without the marker gene (F/+) and lacked the cre transgene. Selected offspring from these matings were used for the experiments reported here. Control animals were alpha 1 homozygous wild type (+/+) with or without the cre transgene; knock-out animals were homozygous for the alpha 1 null allele (-/-) and harbored the cre transgene. Thus, the mice used for the present studies were of the F4 generation and were composed of a mixed genetic background consisting of C57BL/6J, strain 129/Sv/SvJ, and FVB/N.

Western blot analysis. Western blot analysis of the GABAA receptor alpha 1 subunit was conducted as described previously (Devaud et al., 1997). In brief, P2 membrane fractions from whole mouse brain were prepared by homogenization in PBS buffer (150 mM NaCl and 10 mM Na2HPO4-NaH2PO4, pH 7.4). Aliquots of 15 µg/lane protein were separated by SDS-PAGE under reducing conditions using a Novex (San Diego, CA) Xcell II minicell apparatus. Proteins were transferred to polyvinylidine fluoride membranes (Immobilon-P; Millipore, Bedford, MA). Blots were probed with GABAA receptor anti-peptide alpha 1, amino acid 1-16 (Gao et al., 1993), or actin (Chemicon, Temecula, CA) antibodies. Blots were then probed with horseradish peroxidase-conjugated anti-guinea pig (alpha 1) or anti-mouse (actin) antibodies. Specific peptide labeling was detected by enhanced chemiluminescence (Pierce, Rockford, IL). Blots were apposed to x-ray film under nonsaturating conditions.

Electrophysiology. Sagittal slices of cerebellum (150-200 µm) were prepared from postnatal day 11 (P11) and P35 mice. Cerebellar neurons were viewed with an upright microscope (Axioscope, Zeiss, Germany) equipped with Nomarski optics and an electrically insulated water immersion 60× objective with a long working distance (2 mm). Experiments were performed at room temperature (22-24°C) using an extracellular medium composed of (in mM): 120 NaCl, 3.1 KCl, 1.25 K2HPO4, 26 NaHCO3, 5.0 dextrose, 1.0 MgCl2, and 2.0 CaCl2 containing 2 mM kynurenic acid (Aldrich, Milwaukee, WI) to block excitatory amino acid-mediated synaptic transmission. The solution was maintained at pH 7.4 by bubbling with 5% CO2 plus 95% O2. The slice was continuously perfused at a rate of 5 ml/min and completely submerged in a total volume of 500 µl. Zolpidem and flurazepam (Sigma, St Louis, MO) were dissolved in dimethylsulfoxide (<0.001% final concentration) and water, respectively, diluted in the extracellular medium, and superfused through a parallel input to the perfusion chamber until effective replacement of the solution was obtained. mIPSCs, a subset of sIPSCs, were recorded in the presence of TTX (1 µM; Sigma).

Cells were accepted as stellate cells only if spontaneous firing of action potentials was observed during seal formation (Llano and Gerschenfeld, 1993; Nusser et al., 1997; Kondo and Marty, 1998). Whole-cell voltage-clamp recordings of sIPSCs and mIPSCs were made with an Axopatch-1D amplifier (Axon Instruments, Foster City, CA), after capacitance and series resistance compensation. Series resistance was typically <15 MOmega and was checked for constancy throughout the experiments. Electrodes were pulled from borosilicate glass capillaries (Wiretrol II; Drummond, Broomall, PA) and were filled with a solution containing (in mM): 145 CsCl, 5.0 EGTA, 5.0 MgATP, and 10 HEPES to pH 7.2 with CsOH. Currents were filtered at 2 kHz with an eight-pole low-pass Bessel filter (Frequency Devices, Haverhill, MA), digitized using a personal computer-compatible microcomputer equipped with a Digidata 1200 data acquisition board (Axon Instruments) and pClamp8 (Axon Instruments) software. Off-line data analysis, curve fitting, and figure preparation were performed with Origin (MicroCal Software, Northampton, MA), pClamp 8.0 (Axon Instruments), and Mini Analysis (Synaptosoft, Leonia, NJ) software. For each cell, mIPSC were averaged from 50 events aligned on the point of steepest rise. Peak amplitudes were measured at the absolute maximum of the currents, taking into account the noise of the baseline and noise around the peak. Rise times were measured as the time elapsed from 10 to 90% of the peak amplitude of the response. Curve fitting was performed using simplex algorithm least squares exponential fitting routines with double exponential equations of the form I(t) = If exp(-t/tau f) + Is exp(-t/tau s), where If and Is are the amplitudes of the fast and slow decay components, and tau f and tau s are their respective decay time constants. To compare decay times between different experimental conditions, we used a weighted mean decay time constant tau w = [If/(If + Is)] * tau f + [Is/(If + Is)] * tau s. Zolpidem effects were assessed based on averages of 100 sIPSCs in each neuron by statistical comparisons. Unless otherwise indicated, data are expressed as mean ± SEM; p values represent the results of independent t tests with Bonferroni corrections, or Dunnett's test with prior ANOVA for repeated measures, as appropriate.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Production and characterization of mutant mouse line

A gene targeting construct was used to modify the GABAA receptor alpha 1 subunit in mouse ES cells, as illustrated in Figure 1A. A total of 292 clones were analyzed for gene targeting by Southern blot analysis. After digestion of wild-type ES cell DNA with EcoRI, a ~3.2 kb fragment was hybridized with probe C (Fig. 1A). Targeting at the alpha 1 locus with the vector resulted in two different targeted alleles depending on where the 3' crossover occurred. If the crossover event occurred downstream of the 3'-most loxP site, that loxP site (and accompanying EcoRI site) was present at the targeted locus. This allele was detected on Southern blot analysis of EcoRI-digested DNA as a ~2.2 kb fragment that hybridized to probe C (Fig. 1A, C). In contrast, if the 3' crossover event occurred between the marker gene (i.e., Neo/TK) and the 3'-most loxP site, then that loxP site was absent from the targeted locus. This allele was detected as a ~8.2 kb EcoRI fragment with probe C (data not shown). A total of 19 clones were identified that were correctly targeted that retained the 3'-most loxP site, and 16 clones were identified that had lost the 3'-most loxP site. The fidelity of targeting was also verified with several additional enzymes and probes (data not shown).



View larger version (23K):
[in this window]
[in a new window]
 
Figure 1.   Genetic modification of the alpha 1 subunit of the GABAA-R. A, The gene targeting vector was composed of ~13 kb of homologous genomic DNA, the selectable marker gene PGKneoNTRtkpA (Neo/TK), three loxP sites (arrowheads), and exonic DNA (black box) corresponding to nucleotides 1307-1509 of the GABAA-R alpha 1 subunit cDNA (Keir et al., 1991). Boxes labeled A, B, and C under the wild-type locus represent probes used for Southern blot analyses. The wild-type locus (+) was replaced with the targeting construct by gene targeting in mouse ES cells to yield the targeted locus (Fneo/tk), which contains the marker gene and three loxP sites. CRE recombinase was transiently expressed in heterozygous Fneo/tk cell lines, and clones in which the marker gene had been successfully removed (F) were identified and injected into blastocysts to make chimeric mice. After germ line transmission of the F allele, mice were mated to a CRE deleter strain (Meyers et al., 1998) to create the recombined, null allele (-). HI, BamHI; RI, EcoRI; RV, EcoRV. Arrows indicate size (in approximate kilobases) of relevant restriction fragments. B, Southern blot analysis of mouse tail genomic DNA after digestion with BamHI and hybridization to probe B. C, Western blot analysis of mouse brain homogenates using either alpha 1 GABAA-R or beta -actin-specific antibodies. Note the complete absence of alpha 1 immunoreactive protein in samples from homozygous null allele (-/-) mice.

Before using correctly targeted ES cells to create mice, the selectable marker cassette was removed in vitro by transient expression of CRE recombinase. ES cell clones that survived gancyclovir selection after transient CRE expression were screened for the desired recombination event by Southern blot analysis. As illustrated in Figure 1A, Southern analysis of ES cell DNA digested with BamHI and hybridized with probe A revealed a fragment ~13.0 kb for the wild-type allele (+), ~15.0 kb from the targeted locus with the marker (Fneo/tk), and ~11.0 kb from the targeted allele after CRE-mediated deletion of the marker. Other CRE-mediated recombination events were also distinguished with this same analysis (data not shown). A total of 75 ES cell clones were analyzed, 48 of which harbored the desired recombined locus. We refer to this locus as a floxed locus (F).

Four ES cell clones of the +/F genotype were injected into C57BL/6J blastocysts to make chimeric mice. Two of the four clones yielded highly chimeric mice that transmitted the targeted locus to the next generation. The results presented here were derived from one of the clones (47D12). To convert the F allele to a null allele (-) by recombination of the two remaining loxP sites in vivo, mice harboring the F allele were mated to a general deleter cre transgenic mouse line (Meyers et al., 1998).

All mice were genotyped by Southern blot analysis as illustrated in Figure 1, A and B. In this analysis, after digestion of genomic DNA with BamHI and hybridization of blots with probe B, the wild-type allele (+) is detected as an ~13.0 kb hybridizing fragment, the null allele (-) as an ~11.5 kb fragment, and the targeted allele without the marker gene (F) as an ~2.4 kb fragment.

The exon deleted by CRE-mediated recombination harbors that part of the gene corresponding to nucleotides 1307-1509 of the alpha 1 cDNA (Keir et al., 1991). These nucleotides are predicted to encode amino acids starting in the putative second transmembrane domain and ending in the intercellular loop between transmembranes 3 and 4. This deletion is also expected to create a frame-shift mutation and prevent the in-frame translation of downstream exons.

To verify that the recombined, null allele was indeed incapable of producing functional alpha 1 protein, Western blot analysis of whole-brain membrane proteins was conducted. As shown in Figure 1C, the alpha 1-specific antibody robustly recognized the 51 kDa alpha 1 subunit of the GABAA receptor in extracts from +/+ mice but failed to recognize any immunoreactive protein in extracts from -/- mice. Thus, the gene targeting event followed by CRE-mediated recombination effectively created a GABAA-R alpha 1 subunit null allele.

Mice that lack the alpha 1 subunit of the GABAA receptor are viable, healthy, and overtly indistinguishable from their +/+ and +/- littermates. Detailed phenotypic characterization, including whole animal behavioral responses, drug-induced responses, and pharmacology is ongoing and will be reported in a subsequent communication.

Miniature IPSCs in stellate neurons in mice at P11 and P35

sIPSCs were studied in mouse cerebellar slices by means of whole-cell voltage-clamp recordings from granule and stellate neurons, visually identified by their location and morphological characteristics. The average resting potential and input resistance of cerebellar cells were similar (data not shown) to those described previously in rats (Llano and Gerschenfeld, 1993; Brickley et al., 1996; Nusser et al., 1997). Whole-cell recordings of sIPSCs from granule and stellate neurons voltage clamped at -60 mV were performed using an intracellular pipette solution containing 145 mM CsCl and were observed as inward currents. As reported previously (Llano and Gerschenfeld, 1993; Brickley et al., 1996; Nusser et al., 1997), sIPSCs in stellate neurons were larger and more frequent than in granule neurons (data not shown).

We first investigated 18 stellate neurons at P11 from five different +/+ mice and in 25 neurons from six +/+ mice at P35. Spontaneous IPSCs were observed in all stellate neurons, but their frequency of occurrence was highly variable among different cells. mIPSCs were recorded in the presence of tetrodotoxin (1 µM), which depressed the frequency of occurrence of spontaneous IPSCs. mIPSC frequency was 0.47 ± 0.13 Hz at P11 (mean ± SD) and 0.59 ± 0.11 Hz at P35. mIPSCs had a fast rising time (10-90%; 0.7 ± 0.05 msec at P11 and 0.45 ± 0.08 msec at P35), followed by a double exponential decay, as illustrated in Figure 2B. The mean amplitude of these events in all cells studied in wild-type mice at P11 and P35 are compared in Table 1. The decay time course of the averaged currents was best fitted by two exponential components (Table 1).



View larger version (19K):
[in this window]
[in a new window]
 
Figure 2.   Whole-cell patch-clamp recordings of mIPSCs in stellate cells from mice at P11 and P35. In A, the occurrence of mIPSCs, illustrated on a slow time scale in a neuron from a P11 wild-type mouse, is compared with a neuron from a P35 wild-type mouse. In B, the average of 50 currents recorded from a single stellate neuron is illustrated with a superimposed double exponential curve with the fast (tau f) and slow (tau s) decay time constants indicated and the relative contribution of the fast component to peak amplitude (%F). In C, the weighted time constant from the exponential fitting of these currents from individual cells is compared between mice at different developmental ages. Bars indicate the average values. Data were derived from at least 18 cells from at least five mice in each group. *p < 0.01, statistical significance with respect to P11 mice.


                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Characteristics of mIPSCs recorded from developing stellate neuron cerebellar slices

As reported previously, the exponential decay time constants and the fractional contribution to mIPSC peak amplitude of the fast decay component was variable among cells (Nusser et al., 1997). Figure 2C is a scatter plot of the weighted time constant of decay of the average mIPSC in each cell studied at the two postnatal ages selected. A statistically significant developmental decrease of the duration of mIPSCs can be observed.

Zolpidem differentially affects mIPSCs in developing stellate neurons

To characterize the relative contribution of alpha 1 subunits of GABAA receptors in inhibitory synapses of rat cerebellar granule cells during development, we used the imidazopyridine Zolpidem. This compound has been shown to selectively potentiate alpha 1 subunit-containing GABAA receptor subtypes (Pritchett et al., 1989). As reported previously (Perrais and Ropert, 1999), the effect of Zolpidem on mIPSC peak amplitude relates to the degree of occupancy of postsynaptic GABA receptors. We therefore limited our analysis of the action of the imidazopyridine on the duration of the mISPCs. As illustrated in Figure 3, mIPSCs were recorded in the presence and the absence of Zolpidem. In 12 cells from three +/+ mice at P11, we failed to observe a significant prolongation of mIPSC weighted time constant by two test concentrations of Zolpidem (100 nM and 1 µM) (Fig. 3). In contrast, in 15 cells from six +/+ mice at P35, we observed a statistically significant prolongation of the weighted decay time constant with both concentrations tested (Fig. 3).



View larger version (25K):
[in this window]
[in a new window]
 
Figure 3.   Effects of the imidazopyridine Zolpidem (100 nM) on mIPSCs in cerebellar cells from wild-type mice at P11 and P35. mIPSCs in stellate neurons are illustrated before and after Zolpidem perfusion in a stellate neuron from a P11 mouse (A) and a stellate neuron from a P35 mouse (B). In C, the percentage prolongation of the weighted decay time constants of mIPSCs by two concentrations of Zolpidem is reported for mice at different postnatal ages. Data were derived from at least 12 cells from at least three mice in each group. *p < 0.05, significance with respect to P11 mice.

mIPSCs in stellate neurons from alpha 1 knock-out mice

We recorded from 18 stellate neurons in four mice at P35 that did not express the alpha 1 subunit of the GABAA receptor. In two stellate neurons, mIPSCs were not observed. As seen in Figure 4, mIPSCs amplitude was significantly smaller and the decay was significantly longer in neurons from -/- mice. The results obtained are summarized in Table 1. mIPSCs were no different between 25 neurons from six +/+ mice and 14 neurons from five +/- mice at the same age (Table 1). mIPSCs rising time was 0.45 ± 0.08 msec in +/+ mice and 0.59 ± 0.07 msec in -/- mice. Input resistance and cell capacitance were not different in cells from wild-type and knock-out mice, being 0.93 ± 0.22 GOmega and 6.3 ± 1.4 pF for the +/+ mice and 0.98 ± 0.22 GOmega and 6.7 ± 1.2 pF for the -/- mice. We also recorded mIPSCs from six stellate neurons in two -/- mice and from nine stellate neurons in three +/- mice at P11. As seen in Table 1, mIPSCs amplitude was significantly smaller in neurons from -/- mice than in +/- and +/+ mice. In contrast, the decay was not significantly longer in -/- mice (tau w of 44 ± 6 msec) than in +/+ mice (tau w of 38 ± 8 msec).



View larger version (17K):
[in this window]
[in a new window]
 
Figure 4.   Whole-cell patch-clamp recordings of mIPSCs in stellate cells from genetically altered mice at P35. In A, slow sweeps illustrate the occurrence of mIPSCs in a wild-type mouse and in the homozygote alpha 1 -/-. In B, the average of 50 currents is illustrated with the weighted decay time constant tau w from a double exponential curve fit indicated. In C, the weighted time constant from the exponential fitting of the currents is compared between different genotypes. Bars indicate average values. Data were derived from at least 14 cells from at least four mice in each group. *p < 0.001, statistical significance compared with +/+ mice.

We also investigated the effects of two concentrations of Zolpidem on the duration of mIPSCs recorded in 15 neurons from four -/- P35 mice, 10 neurons from five +/- P35 mice, and 15 neurons from six +/+ P35 mice. As shown in Figure 5, Zolpidem was significantly less efficacious in prolonging the duration of the mIPSCs in stellate neurons from -/- mice. In Figure 5C, the summary of the results is reported; the effects of Zolpidem are significant at both concentrations tested for stellate neurons from both +/+ and +/- mice but not in -/- mice. For comparison, we investigated the effect of a nonselective benzodiazepine, flurazepam, on mIPSC recorded in stellate cells from +/+ and -/- mice. In three stellate neurons from two +/+ mice at P35, flurazepam (30 µM) prolonged the weighted time constant of decay by 220 ± 5%, whereas in three stellate neurons from two -/- mice, the prolongation was 240 ± 20%.



View larger version (26K):
[in this window]
[in a new window]
 
Figure 5.   Effects of the imidazopyridine Zolpidem (100 nM) on mIPSCs in cerebellar stellate cells from genetically altered mice. mIPSCs recorded in stellate neurons are illustrated before and after Zolpidem perfusion in a wild-type mouse (A) and in a homozygote alpha 1 knock-out mouse (B). In C, the percentage prolongation of the decay time constants of mIPSCs by two concentrations of Zolpidem is reported for different mice. Data were derived from at least 10 cells from at least four mice in each group. *p < 0.05, significant with respect to +/+ mice.

sIPSC from granule neurons in alpha 1 deletion mice

As reported previously, TTX (1 µM) strongly depresses the frequency of occurrence of sIPSCs in granule neurons (Brickley et al., 1996; Tia et al., 1996). We therefore studied sIPSCs rather than mIPSCs in granule neurons in cerebellar slices from -/- and +/+ mice at P35. In most neurons from +/+ mice, low-frequency sIPSCs were recorded (10 of 11 cells from four mice). In contrast, in -/- mice, the majority of neurons did not present sIPSCs (four of 16 cells tested from four mice). In those neurons in which sIPSCs were recorded, as can be seen in Figure 6, currents were considerably longer in -/- than in +/+ mice. The summaries of the values of peak amplitude (Fig. 6D) and weighted time constants (Fig. 6E) characterizing sIPSCs are illustrated. As reported for rats (Brickley et al., 1996; Tia et al., 1996; Wall and Usowicz, 1997), a tonic activation of GABAA receptors was observed in granule neurons of mice at P35. This was reflected in a considerable baseline noise in whole-cell recordings, which was sensitive to antagonism by bicuculline (Fig. 6C), indicating the presence of a considerable amount of ambient neurotransmitter in slices from older animals. However, the extent of the outward current produced in granule cells voltage clamped at -60 mV by the application of bicuculline (5 µM) in +/+ mice did not differ significantly from that measured in -/- mice, respectively, 11 ± 1.2 (n = 9) and 12 ± 2.4 (n = 9) pA.



View larger version (38K):
[in this window]
[in a new window]
 
Figure 6.   Whole-cell patch-clamp recordings of sIPSCs in cerebellar granule cells from genetically altered mice. In A, slow sweeps illustrate the occurrence of sIPSCs in a wild-type mouse (+/+) and in the homozygous alpha 1 knock-out (-/-). In B, the average of 50 currents is illustrated. The blockade by bicuculline methiodide (BMI) of a background current in a granule neuron from alpha 1 -/- mice at P35 is illustrated in C. In D and E, the peak amplitude and weighted time constant from the exponential fitting of the currents are compared between different genotypes. Data were derived from at least four cells from at least four mice in each group. *p < 0.001, statistical significance compared with +/+ mice.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Several studies have reported developmental shortening of sIPSCs in cerebellar granule cells (Brickley et al., 1996; Tia et al., 1997). In this study, we extend these findings to cerebellar stellate cells and report that these changes are absent in mice with a deletion of the alpha 1 subunit of GABAA receptors.

The decay of inhibitory currents is regulated in many different ways. Clearance of transmitter from the synaptic cleft (Thompson and Gahwiler, 1992; Draguhn and Heinemann, 1996), multiple vesicle release (Auger and Marty, 1998), and posttranslational mechanisms are all possible determinants of changes in mIPSC decay during development. Our results, however, suggest that the regulation of expression of specific GABAA receptor subunits with development is conceivably the most important event underlying changes in mIPSC decay. Indeed, in mice at P11 when a low-level expression of the alpha 1 subunit was reported (Laurie et al., 1992b), the difference between mIPSCs decay of wild-type and knock-out mice was not significant.

The hypothesis outlined above requires that various GABAA receptor subtypes with distinct subunit isoforms have distinct kinetics. Indeed, this has been demonstrated with recombinant GABAA receptors, in which deactivation of GABA current produced by brief agonist application response is faster when the receptors contain the alpha 1 subunit as opposed to the alpha 2 or alpha 3 subunits (Verdoorn, 1994; Gingrich et al., 1995; Lavoie et al., 1997; McClellan and Twyman, 1999). Shorter GABAergic IPSCs in cerebellar granule cells were proposed to be related to the increased expression of the alpha 6 subunit (Tia et al., 1996). However, the developmental changes also occurred in stellate cells, as reported here, that do not express alpha 6 and in granule cells in mutant mice lacking alpha 6 (Brickley et al., 1999).

These results taken together support our findings and suggest that the developmental increase in alpha 1 subunit expression is responsible for the acceleration of mIPSCs. Previous work related the developmental increase in sensitivity to furosemide to the decrease of mIPSCs duration (Tia et al., 1996). Our results on mIPSCs recorded from granule neurons from alpha 1 knock-out mice suggest that the expression of the alpha 1 subunit is primarily responsible for the developmental decrease of mIPSCs duration. This result together with the developmental increase in sensitivity to furosemide suggest that both alpha 1 and alpha 6 subunits contribute to determine the function and pharmacology of synaptic receptors at inhibitory synapses to cerebellar granule neurons. Indeed, anatomical findings revealed that the alpha 6 and alpha 1 subunits are colocalized in many GABAergic Golgi synapses in granule neurons (Nusser et al., 1998).

Deletion of the alpha 1 subunit causes a significant reduction of mIPSCs amplitude in stellate neurons. This event possibly relates to a decrease in the number of postsynaptic receptors at inhibitory synapses. Surprisingly, this reduction was observed even in -/- mice at P11 when no significant differences in decay kinetics of mIPSCs were seen. The possibility exists that, in wild-type stellate cells at P11, alpha 1 is normally expressed at a very low level. Lack of even a small amount of alpha 1 could either directly, or indirectly through compensatory changes in levels of other subunits, lead to the observed reduction in mIPSC amplitude. The fact that decay kinetics do not change at P11 in the knock-out may suggest that other subunits are present that have a dominant effect on kinetics and mask the absence of alpha 1 on this parameter at this early age. However, by P35, alpha 1 is normally such an abundant subunit in these cells that its absence is no longer masked.

We did not observe changes in the background current prominent in adult rodent cerebellar granule neurons (Brickley et al., 1996; Tia et al., 1996; Wall and Usowicz, 1997). This indicates that the deletion of the alpha 1 subunit does not affect the expression of GABAA receptors containing the alpha 6 subunit, which have been reported to be responsible for this background current (Brickley et al., 1999) and to be also located extrasynaptically in these neurons (Nusser et al., 1998).

To support our proposal that the contribution of alpha 1 subunit-containing GABAA receptors in inhibitory synapses of stellate neurons increases with development, we also studied potentiation of mIPSCs by Zolpidem, an imidazopyridine that has greater potency with GABAA receptors containing alpha 1 subunits (Pritchett et al., 1989; MacDonald and Olsen, 1994). We showed that Zolpidem did not affect mIPSC decay at P11, although it prolongs the decay rate significantly at P35 in wild-type mice. This implies that GABAA receptors containing alpha 1 subunits may not contribute to inhibitory synapses before P11. This result matches the developmental expression pattern of the alpha 1 subunit mRNA in the cerebellum (Bovolin et al., 1992; Laurie et al., 1992b) and supports the hypothesis of an increased contribution of the alpha 1 subunit to inhibitory synapses after P11.

What is the subunit composition of GABA receptors in mice that lack the alpha 1 subunit? At the present time, we can only speculate that the expression of other alpha  subunits, such as alpha 5 (Dunning et al., 2000), alpha 2, or alpha 3, may be responsible for slower mIPSCs similar to those found early in development. Indeed, low levels of mRNA for alpha 2 and alpha 3 subunits were seen early in development (Laurie et al., 1992b), and deactivation of GABA responses in cells transfected with these subunits combination is significantly slower (Verdoorn, 1994; Gingrich et al., 1995; Lavoie et al., 1997; McClellan and Twyman, 1999). The prolongation of decay of mIPSCs seen with flurazepam in -/- mice suggests that GABA receptors in these mice are comprised of beta gamma 2 subunits and possibly an alpha  subunit, although potentiation of currents recorded in heterologous cells expressing only beta gamma subunits has been reported (Sigel et al., 1990; Im et al., 1993). However, the possibility that receptors exclusively assembled with beta gamma subunits are present in the cerebellum of -/- mice seems unlikely given the low level of expression of receptors with this subunit combination in heterologous systems (Sigel et al., 1990; Verdoorn et al., 1990).

It has been demonstrated that thalamic afferents regulate the area-specific expression of the alpha 1 subunit of GABAA receptors in developing rat neocortex (Paysan et al., 1997). This raises the intriguing possibility that expression of the alpha 1 subunit is regulated in an activity-dependent manner. Our results would indicate that a reason for the increased contribution of the alpha 1 subunit at inhibitory synapses is to regulate the strength of inhibitory synapses by controlling the duration of IPSCs via the expression levels of this subunit. The experimental verification of this hypothesis is a challenge for the future.


    FOOTNOTES

Received Nov. 20, 2000; revised Feb. 15, 2001; accepted Feb. 20, 2001.

This work was supported by National Institutes of Health Grants MH01680 (S.V.), AA10422 and GM52035 (G.E.H.), and AA09013 (A.L.M.). We thank Gail Martin for generously providing actin-cre mice, and Joanne Steinmiller, Karen Renzi, Brian Sloat, JianHong Luo, and Ed Mallick for expert technical support.

Correspondence should be addressed to Dr. Stefano Vicini, Department of Physiology and Biophysics, Georgetown University School of Medicine, 3900 Reservoir Road NW, Washington, DC 20007. E-mail svicin01{at}georgetown.edu.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

  • Auger C, Kondo S, Marty A (1998) Multivesicular release at single functional synaptic sites in cerebellar stellate and basket cells. J Neurosci 18:4532-4547[Abstract/Free Full Text].
  • Bovolin P, Santi MR, Memo M, Costa E, Grayson DR (1992) Distinct developmental patterns of expression of rat alpha 1, alpha 5, gamma 2S, and gamma 2L gamma -aminobutyric acidA receptor subunit mRNAs in vivo and in vitro. J Neurochem 59:62-72[ISI][Medline].
  • Brickley SG, Cull-Candy SG, Farrant M (1996) Development of a tonic form of synaptic inhibition in rat cerebellar granule cells resulting from persistent activation of GABAA receptors. J Physiol (Lond) 497:753-759[ISI][Medline].
  • Brickley SG, Farrant M, Wisden B, Cull-Candy SG (1999) The role of alpha 6- and delta -containing GABAA receptors in the generation of tonic inhibition in cerebellar granule cells. J Physiol (Lond) 518P:140.
  • Brussard AB, Kits KS, Baker RE, Willems WPA, Leyting-Vermeulen JW, Voorn P, Smit AB, Bicknell RJ (1997) Plasticity in fast synaptic inhibition of adult oxytocin neurons caused by switch in GABAA receptor subunit expression. Neuron 19:1103-1114[ISI][Medline].
  • Devaud LL, Fritschy J-M, Sieghart W, Morrow AL (1997) Bidirectional alterations of GABAA receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. J Neurochem 69:126-130[ISI][Medline].
  • Draguhn A, Heinemann U (1996) Different mechanisms regulate IPSC kinetics in early postnatal and juvenile hippocampal granule cells. J Neurophysiol 76:3983-3993[Abstract/Free Full Text].
  • Dunning DD, Hoover CL, Soltesz I, Smith MA, O'Dowd DK (1999) GABAA receptor-mediated miniature postsynaptic currents and alpha  subunit expression in developing cortical neurons. J Neurophysiol 82:3286-3297[Abstract/Free Full Text].
  • Farrant M, Wisden W, Cull-Candy S, Brickley SG (1999) Absence of tonic GABAA mediated conductance in cerebellar granule cells of alpha 6 -/- mice Soc Neurosci Abstr 25:499.6.
  • Gao B, Fritschy J-M, Benke D, Mohler H (1993) Neuron-specific expression of GABAA-receptor subtypes: differential association of the alpha 1 and alpha 3 subunits with serotonergic and GABAergic neurons. Neuroscience 54:881-892[ISI][Medline].
  • Gingrich KJ, Roberts WA, Kass RS (1995) Dependence of the GABAA receptor gating kinetics on the a-subunit isoform: implications for structure-function relations and synaptic transmission. J Physiol (Lond) 489:529-543[ISI][Medline].
  • Hollrigel GS, Soltesz I (1997) Slow kinetics of miniature IPSCs during early postnatal development in granule cells of the dentate gyrus. J Neurosci 17:5119-5128[Abstract/Free Full Text].
  • Homanics GE, Ferguson C, Quinlan JJ, Daggett J, Snyder K, Lagenaur C, Mi ZP, Wang XH, Grayson DR, Firestone LL (1997) Gene knockout of the alpha 6 subunit of the gamma -aminobutyric acid type A receptor: lack of effect on responses to ethanol, pentobarbital, and general anesthetics. Mol Pharmacol 51:588-596[Abstract/Free Full Text].
  • Im HK, Im WB, Hamilton BJ, Carter DB, Vonvoigtlander PF (1993) Potentiation of gamma-aminobutyric acid-induced chloride currents by various benzodiazepine site agonists with the alpha 1gamma 2, beta 2gamma 2 and alpha 1beta 2gamma 2 subtypes of cloned gamma -aminobutyric acid type A receptors. Mol Pharmacol 44:866-870[Abstract].
  • Keir WJ, Kozak CA, Chakraborti A, Deitrich RA, Sikela JM (1991) The cDNA sequence and chromosomal location of the murine GABAA alpha 1 receptor gene. Genomics 9:390-395[ISI][Medline].
  • Kondo S, Marty A (1998) Synaptic currents at individual connections among stellate cells in rat cerebellar slices. J Physiol (Lond) 509:221-232[Abstract/Free Full Text].
  • Laurie DJ, Seeburg PH, Wisden W (1992a) The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. II. Olfactory bulb and cerebellum. J Neurosci 12:1063-1076[Abstract].
  • Laurie DJ, Wisden W, Seeburg PH (1992b) The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 12:4151-4172[Abstract].
  • Lavoie AM, Tingey JJ, Harrison NL, Pritchett DB, Twyman RE (1997) Activation and deactivation rates of recombinant GABAA receptor channels are dependent on alpha -subunit isoform. Biophys J 73:2518-2526[Abstract/Free Full Text].
  • Lewandoski M, Meyers EN, Martin GR (1997) Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb Symp Quant Biol 62:159-168[ISI][Medline].
  • Llano I, Gerschenfeld HM (1993) Inhibitory synaptic currents in stellate cells of rat cerebellar slices. J Physiol (Lond) 468:177-200[Abstract/Free Full Text].
  • MacDonald RL, Olsen RW (1994) GABAA receptor channels. Annu Rev Neurosci 17:569-602[ISI][Medline].
  • McClellan AM, Twyman R (1999) Receptor system response kinetics reveal functional subtypes of native murine and recombinant human GABAA receptors. J Physiol (Lond) 515:711-722[Abstract/Free Full Text].
  • Meyers EN, Lewandoski M, Martin GR (1998) An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat Genet 18:136-141[ISI][Medline].
  • Nagy A, Cocza E, Merenties Diaz E, Prideaux VR, Ivanyi E, Markkula M, Rossant J (1990) Embryonic stem cells alone are able to support fetal development in the mouse. Development 110:815-821[Abstract/Free Full Text].
  • Nusser Z, Cull-Candy S, Farrant M (1997) Differences in synaptic GABAA receptor number underlie variation in GABA mini amplitude. Neuron 19:697-709[ISI][Medline].
  • Nusser Z, Sieghart W, Somogyi P (1998) Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J Neurosci 18:1693-1703[Abstract/Free Full Text].
  • Okada M, Onodera K, Van Renterghem C, Sieghart W, Takahashi T (2000) Functional correlation of GABAA receptor subunits expression with the properties of IPSCs in the developing thalamus. J Neurosci 20:2202-2208[Abstract/Free Full Text].
  • Paysan J, Kossel A, Bolz J, Fritschy JM (1997) Area-specific regulation of gamma-aminobutyric acid type A receptor subtypes by thalamic afferents in developing rat neocortex. Proc Natl Acad Sci USA 94:6995-7000[Abstract/Free Full Text].
  • Perrais D, Ropert N (1999) Effect of Zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses. J Neurosci 19:578-588[Abstract/Free Full Text].
  • Pouzat C, Hestrin S (1997) Developmental regulation of basket/stellate cell right-arrow Purkinje cell synapses in the cerebellum. J Neurosci 17:9104-9112[Abstract/Free Full Text].
  • Pritchett DB, Luddens H, Seeburg PH (1989) Type I and Type II GABAA-benzodiazepine receptors produced in transfected cells. Science 245:1389-1392[Abstract/Free Full Text].
  • Schofield PR, Darlison MG, Fujita N, Burt DR, Stephenson FA, Rodriguez H, Rhee LM, Ramachandran J, Reale V, Glencorse TA, Seeburgh PH, Barnard EA (1987) Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family. Nature 328:221-227[Medline].
  • Sigel E, Baur R, Trube G, Mohler H, Malherbe P (1990) The effect of subunit composition of rat brain GABAA receptors on channel function. Neuron 5:703-711[ISI][Medline].
  • Sternberg N, Hamilton D (1981) Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol 150:467-486[ISI][Medline].
  • Thompson SM, Gahwiler BH (1992) Effects of the GABA uptake inhibitor tiagabine on inhibitory synaptic potentials in rat hippocampal slice cultures. J Neurophysiol 67:1698-1701[Abstract/Free Full Text].
  • Tia S, Wang JF, Kotchabhakdi N, Vicini S (1996) Developmental changes of inhibitory synaptic currents in cerebellar granule neurons: role of GABAA receptor alpha 6 subunit. J Neurosci 16:3630-3640[Abstract/Free Full Text].
  • Verdoorn TA (1994) Formation of heteromeric gamma -aminobutyric acidA receptors containing two different alpha  subunits. Mol Pharmacol 45:475-480[Abstract].
  • Verdoorn TA, Draguhn A, Ymer S, Seeburg PH, Sakmann B (1990) Functional properties of recombinant rat GABAA receptors depend upon subunit composition. Neuron 4:919-928[ISI][Medline].
  • Wall MJ, Usowicz MM (1997) Development of action potential-dependent and independent spontaneous GABAA receptor-mediated currents in granule cells of postnatal rat cerebellum. Eur J Neurosci 9:533-548[ISI][Medline].
  • Wu H, Lin X, Jaenisch R (1994) Double replacement: strategy for efficient introduction of subtle mutations into the murine Col1a-1 gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci USA 91:2819-2823[Abstract/Free Full Text].


Copyright © 2001 Society for Neuroscience  0270-6474/01/2193009-08$05.00/0


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
Y. Hu, I. V. Lund, M. C. Gravielle, D. H. Farb, A. R. Brooks-Kayal, and S. J. Russek
Surface Expression of GABAA Receptors Is Transcriptionally Controlled by the Interplay of cAMP-response Element-binding Protein and Its Binding Partner Inducible cAMP Early Repressor
J. Biol. Chem., April 4, 2008; 283(14): 9328 - 9340.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
I. Abidin, U. T. Eysel, V. Lessmann, and T. Mittmann
Impaired GABAergic inhibition in the visual cortex of brain-derived neurotrophic factor heterozygous knockout mice
J. Physiol., April 1, 2008; 586(7): 1885 - 1901.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. R. Peden, C. M. Petitjean, M. B. Herd, M. S. Durakoglugil, T. W. Rosahl, K. Wafford, G. E. Homanics, D. Belelli, J.-M. Fritschy, and J. J. Lambert
Developmental maturation of synaptic and extrasynaptic GABAA receptors in mouse thalamic ventrobasal neurones
J. Physiol., February 15, 2008; 586(4): 965 - 987.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
J. Epsztein, Y. Ben-Ari, A. Represa, and V. Crepel
Late-Onset Epileptogenesis and Seizure Genesis: Lessons From Models of Cerebral Ischemia
Neuroscientist, February 1, 2008; 14(1): 78 - 90.
[Abstract] [PDF]


Home page